Drug Profile

PMI 01

Alternative Names: PMI-01

Latest Information Update: 28 Sep 2022

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Precision Molecular
Class Diagnostic agents; Imaging agents
Mechanism of Action Positron-emission tomography enhancers; Single-photon emission-computed tomography enhancers

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

28 Sep 2022 No recent reports of development identified for phase-I development in Inflammation(Diagnosis) in USA
14 Aug 2019 Precision Molecular plans a phase II trials for Inflammation (Diagnosis)
01 Aug 2019 Phase-I clinical trials in Inflammation (Diagnosis) in USA before August 2019 (D and D Pharmatech pipeline, August 2019)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com